Denali Therapeutics Inc. (DNLI) Earnings
|
Expand Research on DNLI
| Next EPS Date | 7/31/26 *Est. | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -2.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +5.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/12/26  |
Q126 | N/A | -$0.65 | N/A | N/A | $18.57M | N/A | N/A | N/A | ||
| 3/26/26 |
Q425 | -$0.73 | -$0.75 | +$0.02 | N/A | $6.92M | N/A |  | | Details | |
| 3/2/26 |
Q425 | N/A | -$0.75 | N/A | N/A | $6.92M | N/A | N/A | N/A | ||
| 11/6/25 |
Q325 | -$0.74 | -$0.75 | +$0.01 | N/A | $1.36M | N/A | | | Details | |
| 11/3/25 |
Q325 | N/A | -$0.75 | N/A | N/A | $1.36M | N/A | N/A | N/A | ||
| 10/30/25 |
Q325 | N/A | -$0.75 | N/A | N/A | $1.36M | N/A | N/A | N/A | ||
| 8/11/25 | Q225 | -$0.72 | -$0.71 | -$0.01 | N/A | $7.47M | N/A | | | Details | |
| 8/6/25 |
Q225 | N/A | -$0.71 | N/A | N/A | $7.47M | N/A | N/A | N/A |
